Risk factors for graft loss and mortality after renal transplantation according to recipient age: a prospective multicentre study

JM Morales, R Marcén, D del Castillo… - Nephrology Dialysis …, 2012 - academic.oup.com
JM Morales, R Marcén, D del Castillo, A Andres, M Gonzalez-Molina, F Oppenheimer
Nephrology Dialysis Transplantation, 2012academic.oup.com
Background To describe the causes of graft loss, patient death and survival figures in kidney
transplant patients in Spain based on the recipient's age. Methods The results at 5 years of
post-transplant cardiovascular disease (CVD) patients, taken from a database on CVD, were
prospectively analysed, ie a total of 2600 transplanted patients during 2000–2002 in 14
Spanish renal transplant units, most of them receiving their organ from cadaver donors.
Patients were grouped according to the recipient's age: Group A:< 40 years, Group B: 40–60 …
Background
To describe the causes of graft loss, patient death and survival figures in kidney transplant patients in Spain based on the recipient's age.
Methods
The results at 5 years of post-transplant cardiovascular disease (CVD) patients, taken from a database on CVD, were prospectively analysed, i.e. a total of 2600 transplanted patients during 2000–2002 in 14 Spanish renal transplant units, most of them receiving their organ from cadaver donors. Patients were grouped according to the recipient's age: Group A: <40 years, Group B: 40–60 years and Group C: >60 years. The most frequent immunosuppressive regimen included tacrolimus, mycophenolate mofetil and steroids.
Results
Patients were distributed as follows: 25.85% in Group A (>40 years), 50.9% in Group B (40–60 years) and 23.19% in Group C (>60). The 5-year survival for the different age groups was 97.4, 90.8 and 77.7%, respectively. Death-censored graft survival was 88, 84.2 and 79.1%, respectively, and non death-censored graft survival was 82.1, 80.3 and 64.7%, respectively. Across all age groups, CVD and infections were the most frequent cause of death. The main causes of graft loss were chronic allograft dysfunction in patients <40 years old and death with functioning graft in the two remaining groups. In the multivariate analysis for graft survival, only elevated creatinine levels and proteinuria >1 g at 6 months post-transplantation were statistically significant in the three age groups. The patient survival multivariate analysis did not achieve a statistically significant common factor in the three age groups.
Conclusions
Five-year results show an excellent recipient survival and graft survival, especially in the youngest age group. Death with functioning graft is the leading cause of graft loss in patients >40 years. Early improvement of renal function and proteinuria together with strict control of cardiovascular risk factors are mandatory.
Oxford University Press